Biotech’s New Frontiers: Cancer, HIV, and Genetics
Kilder
- statnews.com: Revolution Medicines touts ‘unprecedented’ data for pancreatic cancer pill - statnews.com
- fiercebiotech.com: Revolution’s much-hyped RAS inhibitor hits key survival goals in phase 3 pancreatic cancer trial - Fierce Biotech
- biospace.com: Revolution rises 40% as pancreatic cancer drug doubles survival - BioSpace
- bioworld.com: Revolution’s daraxonrasib nails endpoints in pancreatic cancer trial - BioWorld News
- Nature: Long-term HIV-1 remission achieved through allogeneic haematopoietic stem cell transplant from a CCR5Δ32/Δ32 sibling donor - Nature
- nature.com: Long-term HIV-1 remission achieved through allogeneic haematopoietic stem cell transplant from a CCR5Δ32/Δ32 sibling donor - Nature
- news.google.com: Norway's 'Oslo patient' reaches HIV remission after rare stem cell transplant donated by brother - Medical Xpress
- livescience.com: 'Oslo patient' likely cured of HIV after getting stem cell transplant from his brother, who is genetically resistant to the virus - Live Science
- fiercebiotech.com: Regeneron rides into radiopharma via $2.1B biobucks Telix pact - Fierce Biotech
- biospace.com: Telix and Regeneron Announce Strategic Radiopharma Collaboration - BioSpace
- biospace.com: Regeneron enters radiopharma ring with up to $4.3B Telix alliance - BioSpace
- biospace.com: Regeneron and Telix Announce Strategic Radiopharma Collaboration - BioSpace
- bioworld.com: Regeneron enters radiopharma space via Telix deal - BioWorld News
- Biospace: Novo Nordisk A/S - share repurchase programme - April 13, 2026 - BioSpace
- globenewswire.com: Novo Nordisk A/S - share repurchase programme - GlobeNewswire
- stocktitan.net: Novo Nordisk (NYSE: NVO) details progress on DKK 15B share repurchase - Stock Titan
- Bioworld: GLP-1R drug response tied to variants in target genes - BioWorld News
- bioworld.com: GLP-1R drug response tied to variants in target genes - BioWorld News
- aol.com: Health Rounds: Genetic variations linked to weight loss, side effects from GLP-1 drugs - AOL.com
- earth.com: Why some people lose more weight on GLP-1 drugs - Earth.com
- Labiotech: Amgen pipeline’s next growth cycle: replacing its old blockbusters - Labiotech.eu
- labiotech.eu: Amgen pipeline’s next growth cycle: replacing its old blockbusters - Labiotech.eu
- wikimedia: Photo by NavyMedicine / Wikimedia Commons / Public domain
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.